Advertisement
Singapore markets close in 27 minutes
  • Straits Times Index

    3,323.06
    +8.92 (+0.27%)
     
  • Nikkei

    39,173.15
    +368.50 (+0.95%)
     
  • Hang Seng

    18,072.90
    +45.19 (+0.25%)
     
  • FTSE 100

    8,283.96
    +2.41 (+0.03%)
     
  • Bitcoin USD

    60,721.45
    -1,976.26 (-3.15%)
     
  • CMC Crypto 200

    1,263.98
    +14.86 (+1.19%)
     
  • S&P 500

    5,447.87
    -16.75 (-0.31%)
     
  • Dow

    39,411.21
    +260.91 (+0.67%)
     
  • Nasdaq

    17,496.82
    -192.54 (-1.09%)
     
  • Gold

    2,338.60
    -5.80 (-0.25%)
     
  • Crude Oil

    81.64
    +0.01 (+0.01%)
     
  • 10-Yr Bond

    4.2480
    -0.0090 (-0.21%)
     
  • FTSE Bursa Malaysia

    1,586.69
    -2.97 (-0.19%)
     
  • Jakarta Composite Index

    6,871.90
    -17.27 (-0.25%)
     
  • PSE Index

    6,299.05
    +26.59 (+0.42%)
     

3 Things About Eli Lilly That Smart Investors Know

3 Things About Eli Lilly That Smart Investors Know

Eli Lilly (NYSE: LLY) is getting a lot of Wall Street attention again. Eli Lilly's drug development pipeline is as big as they come, and that means plenty of new medicines are likely to hit the market in any given period. Within the next year, Lilly could commercialize tirzepatide for obesity, donanemab for Alzheimer's disease, empagliflozin for chronic kidney disease, and lebrikizumab for atopic dermatitis.